Can the United States achieve 90-90-90?

被引:18
作者
Hall, H. Irene [1 ]
Brooks, John T. [1 ]
Mermin, Jonathan [2 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA
关键词
antiretroviral therapy; diagnosed infections; HIV care; viral suppression; MISSED OPPORTUNITIES; HIV; ADOLESCENTS; ADULTS; MEN; SEX;
D O I
10.1097/COH.0000000000000578
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review To summarize recent trends in knowledge of HIV status, care and viral suppression, and the status of implementation of relevant contextual requirements for the United States to achieve the 90-90-90 goals. Recently, the US government announced a plan to decrease HIV incidence by over 90% by 2030. Reaching this goal may require higher targets than 90-90-90. Recent findings The United States is on course to reach 90-90-90 goals in the near future, with 86% of persons with HIV aware of their infection, 74% of persons with diagnosed infection in care, and 83% of persons in care with viral suppression in 2016. Some high-burden subnational jurisdictions have already achieved these goals. The United States is likely to reach 90-90-90 targets in the near future. However, to reduce HIV incidence by at least 90% by 2030, the United States will need to rapidly meet the new 95-95-95 targets and deploy a comprehensive strategy with novel approaches to testing, retaining persons with HIV on treatment, and preventing new infections with preexposure prophylaxis and comprehensive syringe services programs.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 40 条
[1]  
[Anonymous], 90 90 90 AMB TREATM
[2]  
[Anonymous], 2018, HIV EP ANN REP 2017
[3]  
[Anonymous], 2015, NAT HIV AIDS STRAT U
[4]   Human Immunodeficiency Virus Epidemic Control in the United States: An Assessment of Proposed UNAIDS Metrics, 2010-2015 [J].
Bosh, Karin A. ;
Brooks, John T. ;
Hall, H. Irene .
CLINICAL INFECTIOUS DISEASES, 2019, 69 (08) :1431-1433
[5]   Data-Driven Goals for Curbing the US HIV Epidemic by 2030 [J].
Bradley, Heather ;
Rosenberg, Eli S. ;
Holtgrave, David R. .
AIDS AND BEHAVIOR, 2019, 23 (03) :557-563
[6]  
Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
[7]   Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study [J].
Branson, Bernard M. ;
Chavez, Pollyanna R. ;
Hanscom, Brett ;
Greene, Elizabeth ;
McKinstry, Laura ;
Buchacz, Kate ;
Beauchamp, Geetha ;
Gamble, Theresa ;
Zingman, Barry S. ;
Telzak, Edward ;
Naab, Tammey ;
Fitzpatrick, Lisa ;
El-Sadr, Wafaa M. .
CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) :1581-1587
[8]   Adherence and Viral Suppression Among Participants of the Patient-centered Human Immunodeficiency Virus (HIV) Care Model Project: A Collaboration Between Community-based Pharmacists and HIV Clinical Providers [J].
Byrd, Kathy K. ;
Hou, John G. ;
Bush, Tim ;
Hazen, Ron ;
Kirkham, Heather ;
Delpino, Ambrose ;
Weidle, Paul J. ;
Shankle, Michael D. ;
Camp, Nasima M. ;
Suzuki, Sumihiro ;
Clay, Patrick G. .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (05) :789-797
[9]  
Camp N, 2019, C RETR OPP INF SEATT
[10]  
Centers for Disease Control and Prevention, 2019, MON SEL NAT HIV PR S, V24